Orthomet
This article was originally published in The Gray Sheet
Executive Summary
Enters hydroxylapatite-coated reconstructive hip market via receipt of FDA clearance of hip stems and cups with HA coating. FDA also has cleared Orthomet's ceramic femoral heads, which represent another segment of the orthopedic market previously not addressed by the firm. Orthomet plans to begin shipping the new products in 30 days....